Yale-led technology receives FDA approval for breast cancer treatment

“The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.

Summary generated from the RSS feed of Yale News - Science & Technology. All article rights belong to the original publisher. Click through to read the full piece on news.yale.edu.